Featured Conference

2nd Annual Pharmaceutical Marketing Compliance Congress
January 31-February 1, 2005 • Washington, DC

Visit the conference website for more information and to register.

The 2005 event reconvenes over 350 high level legal, compliance and regulatory members of the pharmaceutical industry and features tracks on direct-to-consumer advertising, off-label promotion and fraud & abuse.

Keynote Speakers include:

  • Thomas W. Abrams, R.Ph., Director, Division of Drug Marketing Advertising and Communications, (DDMAC), U.S. FDA
  • Thomas Greene, Whistleblower Attorney, Greene & Hoffman
  • Michael Loucks, Healthcare Fraud Chief, U.S. Attorneys Office, District of Massachusetts
  • Executive Keynote Compliance Panel: Valli Baldassano, Vice President, Global Compliance, Schering-Plough
  • L. Stephan Vincze, Vice President, Ethics and Compliance Officer, Privacy Officer, TAP Pharmaceutical Products Inc
  • Michael Shaw, Deputy Compliance Officer, Novartis Pharmaceuticals
  • Janice Toran, Vice President, Compliance, Fujisawa Healthcare
  • Thomas Glavin, Corporate Counsel, Global Compliance, Aventis Pharmaceuticals

Track A: Direct-to-Consumer Advertising

Confirmed Speakers Include:

  • Peter J. Pitts, Senior Vice President, Health Affairs, Manning, Selvage & Lee; Former Associate Commissioner for External Relations, U.S. FDA
  • Mark Eichorn, Senior Attorney, Division of Advertising Practices, Consumer Protection Bureau, Federal Trade Commission
  • Michael Misocky, J.D., R.Ph., Director, PPD Regulatory Affairs, Advertising and Promotion, Abbott Laboratories
  • Joseph S. Sonk, Ph.D., Vice President, Drug Regulatory Affairs, Berlex, Inc.
  • Arnold Friede, Senior Counsel, Pfizer Inc
  • Debra Bromson, Senior Counsel and Chief Privacy Officer, AstraZeneca

Track B: Off-Label Promotion

Confirmed Speakers Include:

  • Geoffrey Levitt, Vice President and Chief Regulatory Counsel, Wyeth Pharmaceuticals
  • Tracy Acker, Director, Drug Regulatory Advertising and Promotion, Johnson & Johnson Pharmaceutical Research and Development
  • Edward Miller, Chief Compliance Officer, Boehringer Ingelheim Pharmaceuticals
  • Nancy Coddington, Ph.D., Director of Compliance, Medical Affairs, AstraZeneca
  • Eric Aaronson, Healthcare Law Compliance, Pfizer Inc
  • T. Reed Stephens, Partner, Sonnenschein Nath & Rosenthal
  • Wendy Goldstein, Partner, Epstein Becker Green
  • Alan Minsk, Partner, Arnall Golden & Gregory
  • Amy Fortenberry, Attorney, Womble CarlyleSandridge & Rice
  • Arthur Levine, Partner, Arnold & Porter

Track C: Fraud & Abuse

Confirmed Speakers Include:

  • Douglas Lankler, Assistant General Counsel and Deputy Corporate Compliance Officer, Pfizer Inc
  • Virginia Gibson, Esq., Assistant U.S. Attorney, Chief, Civil Division, U.S. Department of Justice
  • Ted Acosta, J.D., Global Investigations and Dispute Advisory, Ernst & Young Health Sciences
  • Jack Dodds, Partner, Morgan Lewis
  • Steve Immelt, Partner, Hogan & Hartson
  • Paul Kalb, Partner, Sidley Austin Brown & Wood
  • Theodore W. Frank, Chief Executive Officer, Axentis
  • LaDonna Steiner, Associate General Counsel, Purdue Pharma LP
  • Carolyn McElroy, Counsel, Mintz Levin Cohn Ferris Glovsky & Popeo
  • Lynn Snyder, Partner, Epstein Becker Green
  • Richard Gering, Principal, ParenteNet

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com or visit the conference website.

Return to list of conferences…